Evidence map›Paper›PMID 40458536›Full record

ArticleAmerican journal of ophthalmology case reports2025

Novel use of plasma pen ablation for the treatment of extensive periocular xanthogranuloma: A case report.

Hala M Nassim Ali, Mohammed M Alismail, Hissah S AlTurki, Basheer Aldajani

Abstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hala M Nassim AliHead of Oculoplastic Unit, King Fahd Hospital of the University, Khobar, Saudi Arabia.
Mohammed M AlismailCollege of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
Hissah S AlTurkiOphthalmology Department, Dhahran Eye Specialist Hospital, Dhahran, Saudi Arabia.
Basheer AldajaniCollege of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This case demonstrates a novel technique for treatment of periocular xanthogranuloma using plasma pen ablation, a non-invasive therapy that stimulates skin regeneration. It is used in various conditions, such as benign skin growth removal and non-surgical blepharoplasty, but, to our knowledge, this is the first reported case of periocular xanthogranuloma treated with this method. Observations: A 45-year-old male with dyslipidemia presented with bilateral extensive periocular xanthogranuloma slowly progressing over 10 years, resistant to steroid injection and bleomycin, with positive Touton giant cells on biopsy. The patient underwent 2 procedures, 1 year apart, involving partial excision to achieve 1.5 mm lesion thickness followed by plasma pen ablation with an acupuncture tip. A 12-month and 6-month follow-up after the first and second procedures, respectively, showed effective cosmetic and functional improvement, minimal recurrence, and no notable complications. Conclusion and importance: Due to the extensive and irregular distribution of the lesions, traditional full-thickness excision and skin grafting was not feasible in all affected areas. Thus, a plasma pen was utilized. Plasma pen ablation offers a promising new approach in the management of extensive periocular and primary simple xanthogranuloma. Further research is encouraged to validate these findings.

Indexed as

NovelPeriocularPlasma penTechniqueXanthogranuloma

Identifiers

PMID40458536
PMCPMC12127539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.